Live Breaking News & Updates on Dalimumab

Stay informed with the latest breaking news from Dalimumab on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Dalimumab and stay connected to the pulse of your community

AbbVie raises full year profit guidance as Humira sales fall

Sales of the pharma giant's newer drugs are offsetting its Humira losses.

Roberta-michael , Richarda-gonzalez , Wall-street , Abbvie , Dalimumab , Actset , Erck , Isease-modifying-antirheumatic-drugs , Iosimilar , Harmaceutical-industry , Eytruda

Celltrion Launches 80 Mg YUFLYMA (Adalimumab-aaty) In The U.S. - Healthcare

On January 17, 2024, Celltrion announced the U.S. launch of a new, 80 mg/0.8 ml dosage strength of its HUMIRA® biosimilar, YUFLYMA® (adalimumab-aaty). As we previously reported...

Mondaq , Abbvie , Dalimumab , Iosimilar , Elltrion , Umira , Aunch , Uflyma , Food , Rugs , Ealthcare

A new test could save arthritis patients time, money, and pain. But will it be used?

Erinn Maury knew Remicade wasn't the right drug for Patti Schulte, a rheumatoid arthritis patient the physician saw at her Millersville, Maryland, practice. Schulte's swollen, painful joints hadn't responded to Enbrel or Humira, two drugs in the same class.

Maryland , United-states , San-diego , California , London , City-of , United-kingdom , Kentucky , Stanford , Leicestershire , New-york , Millersville

Meta deleted a network of 4,800 fake accounts

Plus: What will be the fate of crypto celebs?

California , United-states , Dubai , Dubayy , United-arab-emirates , East-timor , Cambodia , Italy , Laos , China , Vietnam , Republic-of

Using TNF inhibitors during pregnancy not associated with worse fetal or obstetric outcomes

According to new research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, continuing tumor necrosis factor inhibitors during pregnancy is not associated with worse fetal or obstetric outcomes and may reduce the risk of severe maternal infections during pregnancy (Abstract #0477).

France , Paris , France-general- , French , Megan-craig , American-college-of-rheumatology , American-college , Anna-molto , Cochin-hospital , Pregnancy , Dalimumab , Rthritis

Novel and emerging therapies offer new hope for patients with inflammatory bowel disease

Ulcerative colitis (UC) and Crohn's disease (CD) are chronic inflammatory bowel diseases (IBD) that affect the gastrointestinal tract.

Lily-ramsey , International-organisation , Inflammatory-bowel-diseases , Selecting-therapeutic-targets , Inflammatory-bowel-disease , Dalimumab , Ell , Ell-adhesion , Hildren , Ytokine , Rugs

Effectiveness of Lactobacillus in treating inflammatory bowel disease

The role of Lactobacillus in treating inflammatory bowel disease.

Cell-death-discovery , Inflammatory-bowel-disease , Actobacillus , Bdominal-pain , Dalimumab , Nti-inflammatory , Poptosis , Rchaea , Acteria , Ell , Ell-death

How have inflammatory bowel disease treatments changed after the introduction of biologics?

Researchers compared changes in inflammatory bowel disease treatment strategies before and after the introduction of biologics in Japan.

Japan , Japanese , Scientific-reports , Far-east , Ulcerative-colitis , Inflammatory-bowel-disease , Dalimumab , Hronic , Orticosteroid , Rugs , Ndoscopy

Health Matters | India Mustn't Take Shortcuts for Making Biosimilars, Confusing Affordability with Efficacy Bad Idea

Health Matters India shortcuts making biosimilars confusing affordability efficacy bad idea; generics biosimilars separate strategies approaches; Centre ensure tighter controls before approval periodic quality checks every batch consistent quality; biosimilar Adalimumab Zydus group; biosimilars generic equivalents biologic drugs a new class of medicines more complex than chemical generics; India poised another success story triumph capturing global market generic medicines; eyes trained on market for biosimilars; biologics products derived large molecules monoclonal antibodies gene therapies hormones enzymes; substances classified biologics production living cells organisms; latest news on news18.com; Himani Chandna

United-kingdom , Germany , Manipal , Karnataka , India , Poonam-patil , Bejon-misra , Dinesh-thakur , Similar-biologics , Clinical-trials-registry , Lourdes-hospital

Are antidrug antibodies affecting rheumatoid arthritis treatment ?

Researchers examined the association between antidrug antibodies and the response to treatments for rheumatoid arthritis.

Netherlands , United-kingdom , France , Italy , European-league-against-rheumatism , Biologic-drugs , Patients-with-rheumatoid-arthritis , Antidrug-antibodies , European-anti-biopharmaceutical-immunization , Antibodies , Rthritis